World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
114
Citations
47181
World Ranking
4743
National Ranking
60

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Jakob Passweg is affiliated with the University Hospital of Basel in Switzerland. Their research is primarily situated within the field of Medicine, with a strong focus on Hematology among other subfields such as Genetics, Oncology, Public Health, Environmental and Occupational Health, and Immunology.

The main topics of their work include hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, chronic myeloid leukemia treatments, myeloproliferative neoplasms diagnostics and treatment, chronic lymphocytic leukemia research, and CAR-T cell therapy research.

Jakob Passweg has published extensively in scientific journals, with frequent contributions to venues such as Bone Marrow Transplantation, Blood, Transplantation and Cellular Therapy, Haematologica, and HemaSphere.

Notable recent papers authored or co-authored by Jakob Passweg include:

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years, 2021, Bone Marrow Transplantation
  • The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus, 2020, Bone Marrow Transplantation
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology
  • Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia, 2022, New England Journal of Medicine
  • One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors, 2021, Haematologica

The scientist collaborates frequently with a group of co-authors, including Ibrahim Yakoub-Agha, Nicolaus Kröger, Yves Chalandon, Mohamad Mohty, and Donal P. McLornan, reflecting a broad network within their research community.

Best Publications

  • A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    Robert Kralovics;Francesco Passamonti;Andreas S. Buser;Soon Siong Teo

  • Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients

    Hans H Hirsch;Wendy Knowles;Michael Dickenmann;Jakob Passweg

  • Solid Cancers after Bone Marrow Transplantation

    Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner

  • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

    G Socié;J V Stone;J R Wingard;D Weisdorf

  • Molecular Minimal Residual Disease in Acute Myeloid Leukemia

    Mojca Jongen-Lavrencic;Tim Grob;Diana Hanekamp;François G Kavelaars

  • Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

    Pontus Lundberg;Axel Karow;Ronny Nienhold;Renate Looser

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini

  • High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

    Monique Terwijn;Wim L J van Putten;Angèle Kelder;Vincent H J van der Velden

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

  • One million haemopoietic stem-cell transplants: a retrospective observational study

    Alois Gratwohl;Marcelo C Pasquini;Mahmoud Aljurf;Yoshiko Atsuta

  • Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

    Anna Locasciulli;Rosi Oneto;Andrea Bacigalupo;Gerard Socie

  • Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

    J R Passweg;H Baldomero;P Bader;C Bonini

  • Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

    Alois Gratwohl;Martin Stern;Ronald Brand;Jane Apperley

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

    Andrea Bacigalupo;Ronald Brand;Rosi Oneto;Barbara Bruno

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

    A.S. Fassas;J. R. Passweg;A. Anagnostopoulos;A. Kazis

  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

    Dietger Niederwieser;Helen Baldomero;Jeff Szer;Michael Gratwohl

Frequent Co-Authors

André Tichelli
André Tichelli University Hospital of Basel
Gérard Socié
Gérard Socié Université Paris Cité
Alois Gratwohl
Alois Gratwohl University of Basel
Arnon Nagler
Arnon Nagler Sheba Medical Center
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Jürgen Finke
Jürgen Finke University of Freiburg
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers a huge variety of career paths beyond becoming a doctor. Many students pursue healthcare roles that require less time in school while still making a difference in patient care. For example, medical billing and coding is a fast-growing field where you can earn a credential online. Explore the best medical billing and coding schools online to find programs with strong outcomes and financial aid options.

If you are interested in becoming a nurse, there are absn programs that don't require teas or lengthy entrance exams, making it easier to fast-track your way to an RN license.

Several accelerated healthcare programs can help you quickly transition into roles in healthcare management, hospital administration, or public health—with flexible online formats suited for working adults.

Already an RN? Consider bridging to advanced practice by checking out adn to np programs, enabling you to become a nurse practitioner through an efficient, online curriculum.

Best Scientists Citing Jakob Passweg

Trending Scientists

Recently Published Articles